New clinical trial design in precision medicine: discovery, development and direction

XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

Treatments for COVID-19

HS Andrews, JD Herman… - Annual review of medicine, 2024 - annualreviews.org
The treatment for COVID-19 has evolved rapidly since the start of the pandemic and now
consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir …

Diabetes mellitus, energy metabolism, and COVID-19

C Conte, E Cipponeri, M Roden - Endocrine Reviews, 2024 - academic.oup.com
Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

[HTML][HTML] The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation

R Knoll, ET Helbig, K Dahm, O Bolaji, F Hamm… - Cell, 2024 - cell.com
Dexamethasone is a life-saving treatment for severe COVID-19, yet its mechanism of action
is unknown, and many patients deteriorate or die despite timely treatment initiation. Here, we …

National Institutes of Health COVID-19 treatment guidelines panel: perspectives and lessons learned

RM Gulick, AK Pau, E Daar, L Evans… - Annals of Internal …, 2024 - acpjournals.org
Description: In March 2020, the White House Coronavirus Task Force determined that
clinicians in the United States needed expert treatment guidelines to optimally manage …

Corticosteroids in COVID-19: pros and cons

A Bahsoun, Y Fakih, R Zareef, F Bitar, M Arabi - Frontiers in medicine, 2023 - frontiersin.org
The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Low-dose corticosteroids for critically ill adults with severe pulmonary infections: a review

R Pirracchio, B Venkatesh, M Legrand - JAMA, 2024 - jamanetwork.com
Importance Severe pulmonary infections, including COVID-19, community-acquired
pneumonia, influenza, andPneumocystispneumonia, are a leading cause of death among …

The efficacy of oral/intravenous corticosteroid use in COVID-19 patients: a systematic review

IR Latarissa, F Rendrayani, GN Iftinan… - Journal of …, 2024 - Taylor & Francis
The COVID-19 pandemic is prompting extensive investigation into potential treatments,
including the use of corticosteroids to manage inflammation and mitigate severe disease …

Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19

LPA Neyton, RK Patel, A Sarma, A Willmore… - Nature …, 2024 - nature.com
Dexamethasone is the standard of care for critically ill patients with COVID-19, but the
mechanisms by which it decreases mortality and its immunological effects in this setting are …

Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis

TAC Snow, N Arulkumaran, M Singer, SH Choi - Journal of Infection, 2023 - Elsevier
Introduction The impact of different doses of dexamethasone on outcomes from acute
COVID-19 pneumonia is unknown. Methods We performed a systematic review and meta …